Irvine, CA, United States of America

Xuning Guo


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Xuning Guo: Innovator in Cancer Treatment

Introduction

Xuning Guo is a prominent inventor based in Irvine, CA, who has made significant contributions to the field of cancer treatment. With a focus on developing novel therapeutic compounds, Guo's work is aimed at improving the lives of patients in need of effective cancer therapies. His innovative approach has led to the filing of multiple patents, showcasing his commitment to advancing medical science.

Latest Patents

Guo holds 2 patents, with his latest inventions centered around RAD51 inhibitors. These novel compounds are designed to prevent or treat cancer in subjects who require such interventions. The patents detail methods for administering therapeutically effective amounts of these compounds, highlighting their potential in cancer prevention and treatment.

Career Highlights

Xuning Guo is affiliated with the University of California, where he conducts research and develops his innovative ideas. His work has garnered attention in the scientific community, and he continues to explore new avenues for cancer treatment through his inventions.

Collaborations

Guo collaborates with esteemed colleagues, including Jiewen Zhu and Wen-Hwa Lee, to further enhance the impact of his research. These partnerships are essential in driving forward the development of effective cancer therapies.

Conclusion

Xuning Guo's contributions to cancer treatment through his innovative patents demonstrate his dedication to improving patient outcomes. His work at the University of California and collaborations with fellow researchers position him as a key figure in the ongoing fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…